“…TBC1D4 expression was studied on different mammalian models, including human [24,16,12,34], mouse [20,23,26,27,29,33], rat [22,21,28,11,13,14], mares [19], and pigs [30]. Skeletal muscle was most extensively studied tissue, including muscle biopsy samples as well as cultured myocytes [16,19,20,22,21,24,30,26,27,11,28,13,33], followed by adipose tissue and cultured preadipocytes/adipocytes [16,24,30,23,12,28,29,14]. Type 2 diabetes was shown to decrease expression of Tbc1d4 in skeletal muscle of streptozocin-treated rats [11] and diabetic Goto-Kakizaki rats (in comparison to control Wistar rats) [13].…”